U.S. Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service (Transportation, Warehousing & Storage), By Product (Specialty Drugs, Plasma Derived Products), And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Estimates and forecast timeline
                   1.2. Market Definitions
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                           1.7.1.1. Approach 1: Commodity flow approach
                       1.7.2. Volume price analysis (Model 2)
                           1.7.2.1. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Abbreviations
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Biopharmaceutical Third-Party Logistics (3PL) Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                       3.2.2. Market Restraint Analysis
                   3.3. Technology Landscape
                   3.4. Pricing Model Analysis
                   3.5. Industry Ecosystem Analysis
                   3.6. Market Analysis Tools
                       3.6.1. Porter’s Five Forces Analysis
                       3.6.2. PESTEL Analysis
                       3.6.3. COVID-19 Impact Analysis
Chapter 4. U.S. Biopharmaceutical Third-Party Logistics Market: Supply Chain Estimates & Trend Analysis
                   4.1. Segment Dashboard
                   4.2. Biopharmaceutical Third-Party Logistics Market: Supply Chain Movement Analysis
                   4.3. U.S. Biopharmaceutical Third-Party Logistics (3PL) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   4.4. Cold Chain
                       4.4.1. Cold Chain Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   4.5. Non-Cold Chain
                       4.5.1. Non-Cold Chain Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. U.S. Biopharmaceutical Third-Party Logistics Market: Service Estimates & Trend Analysis
                   5.1. Segment Dashboard
                   5.2. Biopharmaceutical Third-party Logistics Market: Service Movement Analysis
                   5.3. U.S. Biopharmaceutical Third-Party Logistics (3PL) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.4. Transportation
                       5.4.1. Transportation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       5.4.2. Air Freight
                           5.4.2.1. Air Freight Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       5.4.3. Sea Freight
                           5.4.3.1. Sea Freight Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       5.4.4. Overland Transportation
                           5.4.4.1. Overland Transportation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.5. Warehousing & Storage
                       5.5.1. Warehousing & Storage Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.6. Others
                       5.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. U.S. Biopharmaceutical Third-Party Logistics Market: Product Estimates & Trend Analysis
                   6.1. Segment Dashboard
                   6.2. Biopharmaceutical Third-Party Logistics Market: Product Movement Analysis
                   6.3. U.S. Biopharmaceutical Third-Party Logistics (3PL) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.4. Specialty Drugs
                       6.4.1. Specialty Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.5. Generics
                       6.5.1. Generics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.6. Plasma Derived Products
                       6.6.1. Plasma Derived Products Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.7. Others
                       6.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
                   7.1. Company Categorization
                       7.1.1. Market Leaders
                       7.1.2. Emerging Players
                   7.2. Company Market Position Analysis
                   7.3. Company Profiles
                       7.3.1. UPS Healthcare
                           7.3.1.1. Company Overview
                           7.3.1.2. Financial Performance
                           7.3.1.3. Service Benchmarking
                           7.3.1.4. Strategic Initiatives
                       7.3.2. Cardinal Health
                           7.3.2.1. Company Overview
                           7.3.2.2. Financial Performance
                           7.3.2.3. Service Benchmarking
                           7.3.2.4. Strategic Initiatives
                       7.3.3. KUEHNE + NAGEL
                           7.3.3.1. Company Overview
                           7.3.3.2. Financial Performance
                           7.3.3.3. Service Benchmarking
                           7.3.3.4. Strategic Initiatives
                       7.3.4. AmerisourceBergen Corp.
                           7.3.4.1. Company Overview
                           7.3.4.2. Financial Performance
                           7.3.4.3. Service Benchmarking
                           7.3.4.4. Strategic Initiatives
                       7.3.5. McKesson Corporation
                           7.3.5.1. Company Overview
                           7.3.5.2. Financial Performance
                           7.3.5.3. Service Benchmarking
                           7.3.5.4. Strategic Initiatives
                       7.3.6. Thermo Fisher Scientific
                           7.3.6.1. Company Overview
                           7.3.6.2. Financial Performance
                           7.3.6.3. Service Benchmarking
                           7.3.6.4. Strategic Initiatives
                       7.3.7. DHL International GmbH
                           7.3.7.1. Company Overview
                           7.3.7.2. Financial Performance
                           7.3.7.3. Service Benchmarking
                           7.3.7.4. Strategic Initiatives
                       7.3.8. DB Schenker
                           7.3.8.1. Company Overview
                           7.3.8.2. Financial Performance
                           7.3.8.3. Service Benchmarking
                           7.3.8.4. Strategic Initiatives
                       7.3.9. Kerry Logistics Network Ltd.
                           7.3.9.1. Company Overview
                           7.3.9.2. Financial Performance
                           7.3.9.3. Service Benchmarking
                           7.3.9.4. Strategic Initiatives
                       7.3.10. CEVA Logistics
                           7.3.10.1. Company Overview
                           7.3.10.2. Financial Performance
                           7.3.10.3. Service Benchmarking
                           7.3.10.4. Strategic Initiatives
                       7.3.11. Agility Logistics
                           7.3.11.1. Company Overview
                           7.3.11.2. Financial Performance
                           7.3.11.3. Service Benchmarking
                           7.3.11.4. Strategic Initiatives
                       7.3.12. SF Express
                           7.3.12.1. Company Overview
                           7.3.12.2. Financial Performance
                           7.3.12.3. Service Benchmarking
                           7.3.12.4. Strategic Initiatives
                       7.3.13. XPO Logistics
                           7.3.13.1. Company Overview
                           7.3.13.2. Financial Performance
                           7.3.13.3. Service Benchmarking
                           7.3.13.4. Strategic Initiatives
                       7.3.14. Cencora, Inc.
                           7.3.14.1. Company Overview
                           7.3.14.2. Financial Performance
                           7.3.14.3. Service Benchmarking
                           7.3.14.4. Strategic Initiatives
                       7.3.15. EVERSANA
                           7.3.15.1. Company Overview
                           7.3.15.2. Financial Performance
                           7.3.15.3. Service Benchmarking
                           7.3.15.4. Strategic Initiatives
 

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. Biopharmaceutical Third-Party Logistics (3PL) Market by Supply Chain, 2018 - 2030 (USD Billion)
Table 4. U.S. Biopharmaceutical Third-Party Logistics (3PL) Market by Service, 2018 - 2030 (USD Billion)
Table 5. U.S. Biopharmaceutical Third-Party Logistics (3PL) Market by Product, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Biopharmaceutical Third-Party Logistics, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Porter’s Five Forces Analysis
Fig. 10 PESTEL By SWOT Analysis
Fig. 11 U.S. Biopharmaceutical Third-Party Logistics, for Cold Chain Logistics, 2018 - 2030 (USD Million)
Fig. 12 U.S. Biopharmaceutical Third-Party Logistics, for Non-cold Chain Logistics, 2018 - 2030 (USD Million)
Fig. 13 U.S. Biopharmaceutical Third-Party Logistics, for Transportation, 2018 - 2030 (USD Million)
Fig. 14 U.S. Biopharmaceutical Third-Party Logistics, for Air Freight, 2018 - 2030 (USD Million)
Fig. 15 U.S. Biopharmaceutical Third-Party Logistics, for Sea Freight, 2018 - 2030 (USD Million)
Fig. 16 U.S. Biopharmaceutical Third-Party Logistics, for Overland, 2018 - 2030 (USD Million)
Fig. 17 U.S. Biopharmaceutical Third-Party Logistics, for Warehousing and Storage, 2018 - 2030 (USD Million)
Fig. 18 U.S. Biopharmaceutical Third-Party Logistics, for Other Services, 2018 - 2030 (USD Million)
Fig. 19 U.S. Biopharmaceutical Third-Party Logistics, for Specialty Drugs, 2018 - 2030 (USD Million)
Fig. 20 U.S. Biopharmaceutical Third-Party Logistics, for Generics, 2018 - 2030 (USD Million)
Fig. 21 U.S. Biopharmaceutical Third-Party Logistics, for Plasma Derived Products, 2018 - 2030 (USD Million)
Fig. 22 U.S. Biopharmaceutical Third-Party Logistics, for Others, 2018 - 2030 (USD Million)